BioSpace

Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

Patients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.

By BioSpace

1 min read
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights